dr thomas levy glutathione The Only Cause of Disease with Levy, MD, JD Unified Theory of Disease: Everything

Neutralizing antibodies to block viral entry and for identification of entry inhibitors

Historically, the first-line treatment of type 2 diabetes was insulin

Takamura, Y., Tomomatsu, T., Kubo, E., Tsuzuki, S

Compliance note Research compound

The aim of this paper is to bring attention to a compound with a long history of safe use in wound healing and antiaging skin care

Key Discovery Milestones With active concentrations in the nanomolar range (10 M) and a safety margin 300-fold above therapeutic doses, GHK-Cu combines potent biological activity with an excellent safety profile established through decades of clinical use and research studies published in peer-reviewed journals like PubMed